ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 275 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $314,739 | -9.1% | 12,110 | 0.0% | 0.04% | -17.4% |
Q1 2024 | $346,346 | -6.5% | 12,110 | 0.0% | 0.05% | -11.5% |
Q4 2023 | $370,566 | +13.1% | 12,110 | -0.7% | 0.05% | -7.1% |
Q3 2023 | $327,787 | -24.6% | 12,199 | 0.0% | 0.06% | -22.2% |
Q2 2023 | $435,016 | +12.7% | 12,199 | -19.7% | 0.07% | +5.9% |
Q1 2023 | $386,055 | -37.4% | 15,199 | 0.0% | 0.07% | -41.9% |
Q4 2022 | $616,471 | +20.6% | 15,199 | -1.6% | 0.12% | +9.3% |
Q3 2022 | $511,000 | -6.1% | 15,448 | 0.0% | 0.11% | +0.9% |
Q2 2022 | $544,000 | -23.5% | 15,448 | -0.0% | 0.11% | -12.4% |
Q1 2022 | $711,000 | -30.6% | 15,453 | 0.0% | 0.12% | -32.8% |
Q4 2021 | $1,025,000 | +6.2% | 15,453 | 0.0% | 0.18% | -3.7% |
Q3 2021 | $965,000 | -24.6% | 15,453 | 0.0% | 0.19% | -25.5% |
Q2 2021 | $1,280,000 | +27.9% | 15,453 | +2.4% | 0.25% | +15.7% |
Q1 2021 | $1,001,000 | -13.6% | 15,089 | 0.0% | 0.22% | -19.3% |
Q4 2020 | $1,158,000 | +78.2% | 15,089 | 0.0% | 0.27% | +52.8% |
Q3 2020 | $650,000 | -0.3% | 15,089 | 0.0% | 0.18% | -3.8% |
Q2 2020 | $652,000 | +50.2% | 15,089 | 0.0% | 0.18% | +21.2% |
Q1 2020 | $434,000 | -54.6% | 15,089 | 0.0% | 0.15% | -43.4% |
Q4 2019 | $957,000 | +126.2% | 15,089 | +0.6% | 0.27% | +107.0% |
Q3 2019 | $423,000 | +59.6% | 15,000 | +50.0% | 0.13% | +61.2% |
Q2 2019 | $265,000 | +44.0% | 10,000 | 0.0% | 0.08% | +40.4% |
Q1 2019 | $184,000 | +48.4% | 10,000 | 0.0% | 0.06% | +26.7% |
Q4 2018 | $124,000 | – | 10,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |